Clinical Scorecard: Predicting Treatment Outcomes in Head and Neck Cancer through Machine Learning and Noninvasive Diagnostic Integration
At a Glance
Category
Detail
Condition
Head and neck squamous cell carcinoma (HNSCC)
Key Mechanisms
Integration of clinical, blood, and MRI-based radiomic data with machine learning to predict one-year survival and feeding tube dependence
Target Population
Patients with HNSCC undergoing surgery as initial treatment
Care Setting
Oncology clinical practice with access to imaging and laboratory diagnostics
Key Highlights
HNSCC is a common cancer with significant mortality, influenced by factors like tobacco, alcohol, HPV, and EBV.
Traditional prognostic models (TNM staging, HPV status) are limited in capturing disease heterogeneity.
Machine learning models integrating multimodal data (clinical, blood, MRI radiomics) can predict one-year survival and feeding tube dependence.
Guideline-Based Recommendations
Diagnosis
Use TNM classification and HPV status for initial prognosis estimation.
Incorporate noninvasive biomarkers such as liquid and imaging-based markers to enhance prognostic accuracy.
Management
Consider surgery, radiotherapy, chemotherapy, or multimodal regimens based on clinical evaluation.
Predict feeding tube dependence post-surgery to optimize nutritional support and rehabilitation planning.
Monitoring & Follow-up
Monitor survival status and feeding tube placement during follow-up.
Use machine learning models to identify patients at risk for poor outcomes to tailor supportive care.
Risks
Weight loss, malnutrition, and dysphagia may necessitate enteral nutrition support.
Complex interplay of clinical, biological, and treatment factors complicates outcome prediction.
Patient & Prescribing Data
Surgically treated HNSCC patients with available clinical, blood, and MRI data
Machine learning models trained on multimodal data can stratify patients by risk of mortality and feeding tube dependence at one year, aiding personalized care decisions.
Clinical Best Practices
Collect comprehensive baseline data including clinical parameters, laboratory tests, and contrast-enhanced T1-weighted MRI scans.
Use volumetric tumor segmentation and radiomic feature extraction to capture tumor heterogeneity.
Apply advanced data preprocessing including multivariate imputation and standardization to handle missing data.
Employ machine learning classifiers with cross-validation and hyperparameter tuning to develop robust predictive models.
Incorporate additional treatment data as features to assess their impact on outcome predictions.
Utilize explainability methods (e.g., SHAP values) to interpret model decisions and support clinical trust.
by Melda Yeghaian, Stefano Trebeschi, Marina Herrero-Huertas, Francisco Javier Mendoza Ferradás, Paula Bos, Maarten J. A. van Alphen, Marcel A. J. van Gerven, Regina G. H. Beets-Tan, Zuhir Bodalal, Lilly-Ann van der Velden
Two patients presented months after minimally invasive facial procedures with persistent findings that ultimately revealed retained foreign bodies, according to a recent case series.
